Forsidebilde av showet HeartBeat Podcast

HeartBeat Podcast

Podkast av Mohammed Al-Qadami

engelsk

Teknologi og vitenskap

Deretter 99 kr / Måned. Avslutt når som helst.

  • 20 timer lydbøker i måneden
  • Eksklusive podkaster
  • Gratis podkaster

Les mer HeartBeat Podcast

Welcome to the HeartBeat Podcast, your trusted source for the latest discoveries and advancements in cardiology. This podcast leverages advanced AI tools to analyze, summarize, and transform cutting-edge medical research into high-quality podcast episodes. While artificial intelligence plays a key role in producing and presenting these episodes, the content is carefully curated and crafted to ensure accuracy, reliability, and clarity. Whether you're a doctor, a student, or someone passionate about cardiology, this podcast offers insightful and inspiring episodes that combine the power of tec

Alle episoder

15 Episoder

episode Impella CP: Can Microaxial Flow Pumps Redefine Cardiogenic Shock Treatment? Insights from the DanGer Shock Study cover

Impella CP: Can Microaxial Flow Pumps Redefine Cardiogenic Shock Treatment? Insights from the DanGer Shock Study

In this episode, we explore the DanGer Shock study, which investigated the efficacy of the microaxial flow pump Impella CP in reducing mortality and improving clinical outcomes in patients with STEMI-related cardiogenic shock. We delve into the study's design, statistical findings, clinical recommendations, and the future of mechanical circulatory support in cardiology, highlighting both the benefits and risks of this advanced technology as published in the NEJM. Links to the Podcast * Apple Podcast:⁠⁠⁠Listen on Apple Podcast⁠⁠⁠ [https://podcasts.apple.com/de/podcast/heartbeat-podcast/id1780420300] * Spotify:⁠⁠⁠Listen on Spotify⁠⁠⁠ [https://open.spotify.com/show/7LI3wKiuL3HbBcQioWCaMv] * Amazon Music:⁠⁠⁠Listen on Amazon Music⁠⁠⁠ [https://music.amazon.de/podcasts/eb320513-ff73-475f-93e0-57937e9203cc/heartbeat-podcast?fbclid=IwY2xjawG5QvBleHRuA2FlbQIxMAABHehgNb-myKpeO74FHwaxJi9eNnBiYP4giI5Orppa2a4zHK3Plvt6U-Fs-g_aem_22Cn63anZGmr07k9nJusAQ] * YouTube:⁠⁠⁠Watch on YouTube⁠⁠⁠ [https://www.youtube.com/watch?v=yVIX9SGZQNo&list=PLQj5eDzN8_xeRUjo0-B6RJ2b9hjkZdf3L&ab_channel=AI%D8%A2%D9%81%D9%80%D9%80%D9%80%D8%A7%D9%82] 📚 Source: Study Title: Microaxial Flow Pump or Standard Care in Infarct-Related Cardiogenic Shock (DanGer Shock Trial) Publication Date: April 2024 Journal: NEJM DOI:10.1056/NEJMoa2312572 #MedicalPodcast #Cardiology #CardiogenicShock #ImpellaCP #DanGerShockStudy #MyocardialInfarction #MicroaxialFlowPump #CirculatorySupport #NEJM #HeartFailure #ClinicalResearch #HeartDevices #Podcast

16. feb. 2025 - 10 min
episode Breathing Easier: How Aficamten is Giving New Hope to HCM Patients cover

Breathing Easier: How Aficamten is Giving New Hope to HCM Patients

In this episode, we dive into the lives of patients with hypertrophic cardiomyopathy (HCM) and how Aficamten is offering them hope for a better future. From breathing easier to avoiding surgery, we’ll uncover the real impact of this new treatment backed by the SEQUOIA-HCM trial. If you care about heart health or know someone living with HCM, this one’s for you. Links to the Podcast * Apple Podcast:⁠⁠Listen on Apple Podcast⁠⁠ [https://podcasts.apple.com/de/podcast/heartbeat-podcast/id1780420300] * Spotify:⁠⁠Listen on Spotify⁠⁠ [https://open.spotify.com/show/7LI3wKiuL3HbBcQioWCaMv] * Amazon Music:⁠⁠Listen on Amazon Music⁠⁠ [https://music.amazon.de/podcasts/eb320513-ff73-475f-93e0-57937e9203cc/heartbeat-podcast?fbclid=IwY2xjawG5QvBleHRuA2FlbQIxMAABHehgNb-myKpeO74FHwaxJi9eNnBiYP4giI5Orppa2a4zHK3Plvt6U-Fs-g_aem_22Cn63anZGmr07k9nJusAQ] * YouTube:⁠⁠Watch on YouTube⁠⁠ [https://www.youtube.com/watch?v=yVIX9SGZQNo&list=PLQj5eDzN8_xeRUjo0-B6RJ2b9hjkZdf3L&ab_channel=AI%D8%A2%D9%81%D9%80%D9%80%D9%80%D8%A7%D9%82] 📝Source: Study Title: Aficamten for Symptomatic Obstructive Hypertrophic Cardiomyopathy (SEQUOIA-HCM Trial) Publication Date: May 13, 2024 NEJM.org - SEQUOIA-HCM Trial 🔗Full Study Details:NEJM - SEQUOIA-HCM Study [https://www.nejm.org] 🔗ClinicalTrials.gov:SEQUOIA-HCM NCT05186818 [https://clinicaltrials.gov] #BreathingEasier #HeartHealth #Aficamten #NewHope #SEQUOIAHCM #CardiologyTalk #Podcast #RealImpact #MedicalBreakthroughs #BetterLiving

9. feb. 2025 - 16 min
episode Empagliflozin’s Impact: Long-Term Cardiorenal Protection for CKD Patients cover

Empagliflozin’s Impact: Long-Term Cardiorenal Protection for CKD Patients

In this episode, we explore the groundbreaking results of the EMPA-KIDNEY trial, a large-scale clinical study that highlights the long-term benefits of Empagliflozin (SGLT2 inhibitor) in patients with chronic kidney disease (CKD). We dive into how the treatment slowed disease progression, reduced cardiovascular deaths, and provided lasting benefits even after the therapy ended. Join us as we break down the study’s key findings, discuss their real-world implications, and uncover what makes this treatment a game-changer for CKD management. 🔗 Full Study Details: NEJM - EMPA-KIDNEY Study 🔗 ClinicalTrials.gov: EMPA-KIDNEY NCT03594110 Links to the Podcast * Apple Podcast: ⁠Listen on Apple Podcast⁠ [https://podcasts.apple.com/de/podcast/heartbeat-podcast/id1780420300] * Spotify: ⁠Listen on Spotify⁠ [https://open.spotify.com/show/7LI3wKiuL3HbBcQioWCaMv] * Amazon Music: ⁠Listen on Amazon Music⁠ [https://music.amazon.de/podcasts/eb320513-ff73-475f-93e0-57937e9203cc/heartbeat-podcast?fbclid=IwY2xjawG5QvBleHRuA2FlbQIxMAABHehgNb-myKpeO74FHwaxJi9eNnBiYP4giI5Orppa2a4zHK3Plvt6U-Fs-g_aem_22Cn63anZGmr07k9nJusAQ] * YouTube: ⁠Watch on YouTube⁠ [https://www.youtube.com/watch?v=yVIX9SGZQNo&list=PLQj5eDzN8_xeRUjo0-B6RJ2b9hjkZdf3L&ab_channel=AI%D8%A2%D9%81%D9%80%D9%80%D9%80%D8%A7%D9%82] #Podcast #Empagliflozin #ChronicKidneyDisease #CKDManagement #EMPA_KIDNEY_Study #SGLT2Inhibitors #RenalHealth #CardioRenalProtection #ClinicalResearch #MedicalBreakthroughs #LongTermBenefits

2. feb. 2025 - 15 min
episode Beta-Blockers After Myocardial Infarction: To Stop or Continue? The ABYSS Study Unveiled cover

Beta-Blockers After Myocardial Infarction: To Stop or Continue? The ABYSS Study Unveiled

In this episode of the Heartbeat Podcast, we explore the groundbreaking ABYSS trial, which investigates the controversial topic of beta-blocker therapy in patients with a history of myocardial infarction. Should beta-blockers be continued indefinitely, or is it safe to discontinue them after stabilization? Join us as we delve into the study's methods, findings, and implications for clinical practice. We discuss key outcomes, such as cardiovascular events and quality of life, to provide a comprehensive understanding of this pivotal research. Listen now to discover how this study could reshape post-myocardial infarction care and spark new discussions in cardiology. Links to the Podcast * Apple Podcast: Listen on Apple Podcast [https://podcasts.apple.com/de/podcast/heartbeat-podcast/id1780420300] * Spotify: Listen on Spotify [https://open.spotify.com/show/7LI3wKiuL3HbBcQioWCaMv] * Amazon Music: Listen on Amazon Music [https://music.amazon.de/podcasts/eb320513-ff73-475f-93e0-57937e9203cc/heartbeat-podcast?fbclid=IwY2xjawG5QvBleHRuA2FlbQIxMAABHehgNb-myKpeO74FHwaxJi9eNnBiYP4giI5Orppa2a4zHK3Plvt6U-Fs-g_aem_22Cn63anZGmr07k9nJusAQ] * YouTube: Watch on YouTube [https://www.youtube.com/watch?v=yVIX9SGZQNo&list=PLQj5eDzN8_xeRUjo0-B6RJ2b9hjkZdf3L&ab_channel=AI%D8%A2%D9%81%D9%80%D9%80%D9%80%D8%A7%D9%82] #Cardiology #ABYSSStudy #BetaBlockers #MyocardialInfarction #CardiacCare #ClinicalResearch #HeartHealth #MedicalPodcast #CardiovascularDisease #HealthcareProfessionals

26. jan. 2025 - 16 min
episode The Impact of Mineralocorticoid Receptor Antagonists on Heart Failure: A Comprehensive Meta-Analysis cover

The Impact of Mineralocorticoid Receptor Antagonists on Heart Failure: A Comprehensive Meta-Analysis

Discover the transformative role of Mineralocorticoid Receptor Antagonists (MRAs) in heart failure management. This episode delves into a comprehensive meta-analysis, showcasing their impact on reducing hospitalizations and cardiovascular deaths across various heart failure types, including preserved and reduced ejection fractions. Join us as we uncover the clinical significance of MRAs and their role in advancing cardiology practices. Tune in now and elevate your understanding of cutting-edge heart failure therapies." 🎧 Listen to this episode on your favorite platform: * Apple Podcasts: Heartbeat Podcast on Apple Podcasts [https://podcasts.apple.com/de/podcast/heartbeat-podcast/id1780420300] * Spotify: Heartbeat Podcast on Spotify [https://open.spotify.com/show/7LI3wKiuL3HbBcQioWCaMv] * Amazon Music: Heartbeat Podcast on Amazon Music [https://music.amazon.de/podcasts/eb320513-ff73-475f-93e0-57937e9203cc/heartbeat-podcast?fbclid=IwY2xjawG5QvBleHRuA2FlbQIxMAABHehgNb-myKpeO74FHwaxJi9eNnBiYP4giI5Orppa2a4zHK3Plvt6U-Fs-g_aem_22Cn63anZGmr07k9nJusAQ] * YouTube: Heartbeat Podcast on YouTube [https://www.youtube.com/watch?v=yVIX9SGZQNo&list=PLQj5eDzN8_xeRUjo0-B6RJ2b9hjkZdf3L&ab_channel=AI%D8%A2%D9%81%D9%80%D9%80%D9%80%D8%A7%D9%82] #HeartbeatPodcast #HeartFailure #Cardiology #MedicalResearch #MRAs #MineralocorticoidReceptorAntagonists #HeartHealth #PodcastForDoctors #MedicalPodcast #CardiovascularHealth

19. jan. 2025 - 19 min
Enkelt å finne frem nye favoritter og lett å navigere seg gjennom innholdet i appen
Enkelt å finne frem nye favoritter og lett å navigere seg gjennom innholdet i appen
Liker at det er både Podcaster (godt utvalg) og lydbøker i samme app, pluss at man kan holde Podcaster og lydbøker atskilt i biblioteket.
Bra app. Oversiktlig og ryddig. MYE bra innhold⭐️⭐️⭐️

Velg abonnementet ditt

Mest populær

Tidsbegrenset tilbud

Premium

20 timer lydbøker

  • Eksklusive podkaster

  • Ingen annonser i Podimo shows

  • Avslutt når som helst

2 Måneder for 19 kr
Deretter 99 kr / Måned

Kom i gang

Premium Plus

100 timer lydbøker

  • Eksklusive podkaster

  • Ingen annonser i Podimo shows

  • Avslutt når som helst

Prøv gratis i 14 dager
Deretter 169 kr / måned

Prøv gratis

Bare på Podimo

Populære lydbøker

Ofte stilte spørsmål

Flere spørsmål og svar
Kom i gang

2 Måneder for 19 kr. Deretter 99 kr / Måned. Avslutt når som helst.